Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):227-8

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

EDITORIAL  RAI THERAPY IN ADVANCED DIFFERENTIATED THYROID CANCER: FOCUS ON DOSIMETRY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):227-8

DOI: 10.23736/S1824-4785.19.03209-6

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Radioiodine dosimetry in advanced thyroid cancer

Luca GIOVANELLA 1 , Michael LASSMANN 2

1 Clinic for Nuclear Medicine and Competence Center for Thyroid Diseases, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland; 2 Department of Nuclear Medicine,University Hospital Würzburg, Würzburg, Germany



top of page